Khan Anam, Tansel Aylin, White Donna L, Kayani Waleed Tallat, Bano Shah, Lindsay Jan, El-Serag Hashem B, Kanwal Fasiha
Department of Medicine, Baylor College of Medicine, Houston, Texas.
Section of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
Clin Gastroenterol Hepatol. 2016 Feb;14(2):191-202.e1-4; quiz e20. doi: 10.1016/j.cgh.2015.07.047. Epub 2015 Aug 6.
BACKGROUND & AIMS: We conducted a systematic review of efficacy of psychosocial interventions in inducing or maintaining alcohol abstinence in patients with chronic liver disease (CLD) and alcohol use disorder (AUD).
We performed structured keyword searches in PubMed, PsychINFO, and MEDLINE for original research articles that were published from January 1983 through November 2014 that evaluated the use of psychosocial interventions to induce or maintain alcohol abstinence in patients with CLD and AUD.
We identified 13 eligible studies that comprised 1945 patients; 5 were randomized controlled trials (RCTs). Delivered therapies included motivational enhancement therapy, cognitive behavioral therapy (CBT), motivational interviewing, supportive therapy, and psychoeducation either alone or in combination in the intervention group and general health education or treatment as usual in the control group. All studies of induction of abstinence (4 RCTs and 6 observational studies) reported an increase in abstinence among participants in the intervention and control groups. Only an integrated therapy that combined CBT and motivational enhancement therapy with comprehensive medical care, delivered during a period of 2 years, produced a significant increase in abstinence (74% increase in intervention group vs 48% increase in control group, P = .02), which was reported in 1 RCT. All studies of maintenance of abstinence (1 RCT and 2 observational studies) observed recidivism in the intervention and control groups. Only an integrated therapy that combined medical care with CBT produced a significantly smaller rate of recidivism (32.7% in integrated CBT group vs 75% in control group, P = .03), which was reported from 1 observational study. However, data were not collected for more than 2 years on outcomes of patients with CLD and AUD.
In a systematic analysis of studies of interventions to induce or maintain alcohol abstinence in patients with CLD and AUD, integrated combination psychotherapy with CBT, motivational enhancement therapy, and comprehensive medical care increased alcohol abstinence. No psychosocial intervention was successful in maintaining abstinence, but an integrated therapy with CBT and medical care appears to reduce recidivism.
我们对心理社会干预措施在诱导或维持慢性肝病(CLD)合并酒精使用障碍(AUD)患者戒酒方面的疗效进行了系统评价。
我们在PubMed、PsychINFO和MEDLINE数据库中进行结构化关键词检索,查找1983年1月至2014年11月发表的评估心理社会干预措施用于诱导或维持CLD合并AUD患者戒酒的原始研究文章。
我们确定了13项符合条件的研究,共纳入1945例患者;其中5项为随机对照试验(RCT)。干预组采用的治疗方法包括动机增强疗法、认知行为疗法(CBT)、动机访谈、支持性疗法和心理教育,可单独使用或联合使用,对照组采用一般健康教育或常规治疗。所有诱导戒酒的研究(4项RCT和6项观察性研究)均报告干预组和对照组参与者的戒酒率有所提高。只有1项RCT报告,在2年期间实施的将CBT和动机增强疗法与综合医疗护理相结合的综合疗法使戒酒率显著提高(干预组提高74%,对照组提高48%,P = 0.02)。所有维持戒酒的研究(1项RCT和2项观察性研究)均观察到干预组和对照组有复饮情况。只有1项观察性研究报告,将医疗护理与CBT相结合的综合疗法复饮率显著降低(综合CBT组为32.7%,对照组为75%,P = 0.03)。然而,未收集CLD合并AUD患者超过2年的结局数据。
在对诱导或维持CLD合并AUD患者戒酒的干预措施研究进行的系统分析中,将CBT、动机增强疗法与综合医疗护理相结合的综合心理治疗可提高戒酒率。没有心理社会干预措施能成功维持戒酒,但CBT与医疗护理相结合的综合疗法似乎可降低复饮率。